Last updated on January 2017

Efficacy and Safety of COMBIGAN in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG)


Brief description of study

The objective of this study is to evaluate the long-term efficacy and safety of COMBIGAN® (brimonidine tartrate/timolol malate) in patients only using COMBIGAN® (brimonidine tartrate/timolol malate) and also in patients who require additional IOP lowering with LUMIGAN® (bimatoprost) 0.01%.

Clinical Study Identifier: NCT02863705

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Clinical Trials Registry Team

Pusan National University Hospital, Pusan National University School of Medicine
Busan, Korea, Republic of
  Connect »

Clinical Trials Registry Team

Yeungnam University Hospital, Yeungnam University College of Medicine
Daegu, Korea, Republic of
  Connect »

Clinical Trials Registry Team

Chungnam National University Hospital, Chungnam National University College of Medicine
Daejeon, Korea, Republic of
  Connect »

Clinical Trials Registry Team

Chonnam National University Hospital, Chonnam National University Medical School
Gwangju, Korea, Republic of
  Connect »

Clinical Trials Registry Team

Seoul National University Bundang Hospital, Seoul National University College of Medicine
Gyeonggi-do, Korea, Republic of
  Connect »

Clinical Trials Registry Team

Seoul National University Hospital, Seoul National University College of Medicine
Seoul, Korea, Republic of
  Connect »

Clinical Trials Registry Team

Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine
Seoul, Korea, Republic of
  Connect »

Clinical Trials Registry Team

Asan Medical Center, University of Ulsan College of Medicine
Seoul, Korea, Republic of
  Connect »

Clinical Trials Registry Team

Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine
Seoul, Korea, Republic of
  Connect »

Clinical Trials Registry Team

Kim's Eye Hospital, Konyang University College of Medicine
Seoul, Korea, Republic of
  Connect »